WALTHAM, Mass.--Genome Therapeutics has completed a sequencing contract for researchers from the Cancer Research Centre at Queen's University in Belfast, UK.

As part of the agreement, Genome Therapeutics sequenced several regions of the human genome for the institute. Using its proprietary sequencing methods, the biotech company created libraries for each clone, generated sequence reads that provided for greater than six-fold coverage of the region, and provided preliminary analysis of the sequenced regions.